Abstract
Background: Since December 2019, there has been an increasing number of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world. As of March 2020, the World Health Organization declared a global pandemic.
Case Presentation: To our best knowledge, this is the first report of a patient with SARS-CoV-2 infection presenting with constrictive pericarditis, possibly from the COVID infection. She was presented after a week of fever, persistent dry cough, and diarrhea. She received a single dose of hydroxychloroquine 400 mg, Oseltamivir 75 mg every 12 hours, lopinavir/ritonavir (Kaletra) 400/100 mg every 12 hours, and levofloxacin 750 mg daily. After 24 hours, she was immediately transferred to the Intensive Care Unit (ICU) because of dyspnea and progressive respiratory failure with a drop of the O2 saturation to 70%.
Conclusion: After a week of progress, her respiratory condition deteriorated again. She was re-admitted to the ICU and she expired. She died due to constrictive pericarditis, most probably caused by SARS-CoV-2.
Keywords: COVID-19, SARS-CoV-2, pneumonia, ARDS, pericarditis, cardiac tamponade.
Infectious Disorders - Drug Targets
Title:Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
Volume: 21 Issue: 7
Author(s): SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mehrnaz Asadi Gharabaghi and Fereshteh Ghiasvand*
Affiliation:
- Department of Infectious Diseases, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran,Iran
Keywords: COVID-19, SARS-CoV-2, pneumonia, ARDS, pericarditis, cardiac tamponade.
Abstract: Background: Since December 2019, there has been an increasing number of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world. As of March 2020, the World Health Organization declared a global pandemic.
Case Presentation: To our best knowledge, this is the first report of a patient with SARS-CoV-2 infection presenting with constrictive pericarditis, possibly from the COVID infection. She was presented after a week of fever, persistent dry cough, and diarrhea. She received a single dose of hydroxychloroquine 400 mg, Oseltamivir 75 mg every 12 hours, lopinavir/ritonavir (Kaletra) 400/100 mg every 12 hours, and levofloxacin 750 mg daily. After 24 hours, she was immediately transferred to the Intensive Care Unit (ICU) because of dyspnea and progressive respiratory failure with a drop of the O2 saturation to 70%.
Conclusion: After a week of progress, her respiratory condition deteriorated again. She was re-admitted to the ICU and she expired. She died due to constrictive pericarditis, most probably caused by SARS-CoV-2.
Export Options
About this article
Cite this article as:
SeyedAlinaghi SeyedAhmad , Ghadimi Maryam , Gharabaghi Asadi Mehrnaz and Ghiasvand Fereshteh*, Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report, Infectious Disorders - Drug Targets 2021; 21 (7) : e160921188928 . https://dx.doi.org/10.2174/1871526520666201209145001
DOI https://dx.doi.org/10.2174/1871526520666201209145001 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
Call for Papers in Thematic Issues
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification
The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Efficacy and Complications of Subcutaneous <i>versus</i> Conventional Cardioverter
Defibrillators: A Systematic Review and Meta-analysis
Current Cardiology Reviews Aortic Regurgitation as a Complication of Electrophysiologic Ablation Techniques: A Narrative Review
Current Cardiology Reviews Imaging in Drug Side Effects
Current Medical Imaging The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
Current Drug Metabolism Mechanisms And Prevention Of TAVI-Related Cerebrovascular Events
Current Pharmaceutical Design Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit
Current Vascular Pharmacology Mechanical Ventilation Following Cardiac Surgery in Children
Current Respiratory Medicine Reviews Descending Necrotizing Mediastinitis: Current Strategies for Diagnosis and Treatment
Current Respiratory Medicine Reviews Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews The Secondary Heart Field: Understanding Conotruncal Defects from a Developmental Perspective
Current Cardiology Reviews COMPLICATIONS OF RECANALIZATION OF CHRONIC TOTAL OCCLUSION
Current Cardiology Reviews Thoracic Trauma in Combat or Austere Environments
Current Respiratory Medicine Reviews Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies
Current Drug Targets Recurrent Episodes of Pericardial Effusion as Isolated Manifestation of Tuberculosis: Case Report
Current Medical Imaging Retrograde Coronary Chronic Total Occlusion Intervention
Current Cardiology Reviews Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Vascular Disease Prevention (Discontinued) Reversing Anticoagulant Therapy
Current Drug Discovery Technologies Hypersensitivity Reactions to Neuromuscular Blocking Agents
Current Pharmaceutical Design Clinical Management of the Cardiovascular Failure in Sepsis
Current Vascular Pharmacology Cardiovascular Magnetic Resonance for Evaluation of Heart Involvement in ANCA-Associated Vasculitis. A Luxury or a Valuable Diagnostic Tool?
Inflammation & Allergy - Drug Targets (Discontinued)